News
-
Prof. Wei Chen Awarded the “Nanoscale Emerging Investigator” Honor by the Royal Society of Chemistry (UK)
Dr. Wei Chen has been recognized for his outstanding contributions and research excellence in nanomedicine and drug delivery technologies, particularly for pioneering innovative approaches to the treatment of cancer, cardiovascular diseases, and inflammatory disorders.
-
-
-
-
-
-
-
-
-
-
-
Scientists Crack the Code of a Cancer-Related Enzyme, Opening Doors to New Treatments
Cancer remains a global health challenge, with approximately 20 million new cases and 9.7 million deaths reported in 2022 by the International Agency for Research on Cancer. Two exciting new studies published in the Journal of the American Chemical Society are shedding light on an enzyme called beta-1,3-galactosyltransferase 5 (β3GalT5), which plays a critical role in producing sugar molecules tied to cancer progression.
-
-
-
-
-
-
Genomics Research Center 20th Anniversary Celebration
To commemorate this milestone, GRC held its 20th Anniversary Celebration on December 11, 2024. We sincerely thank former and current GRC members, collaborators, and esteemed guests for joining us in celebrating the growth and achievements of the GRC.
-
-
The 2024 National Innovation Improvement Award
Congratulations to Dr. Yun-Ru (Ruby) Chen's team winning the 2024 National Innovation Improvement Award. For more details, please see...
-
-
-
-
-
Assistant Professor Wei Chen was selected to represent Academia Sinica at the STS Forum and its Young Leaders Program in Japan
Dr. Chen is recognized for his research expertise in nanomedicine, biomaterials, and drug delivery technology. He plays a leading role in his research field and possesses excellent English proficiency. Recognized by Academia Sinica, he was selected to attend the Science and Technology in Society (STS) Forum and its Young Leaders Program in Kyoto, Japan.
-
-
-
-
-
